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 1 
Summary 1 
Objectives: To investigate the prevalence and molecular epidemiology of Staphylococcus 2 
aureus and methicillin-resistant S. aureus (MRSA) nasal carriage in children.  3 
Methods: We collected nasal and nasopharyngeal swabs from 2211 children aged 2-5 years 4 
attending 79 day care centers (DCCs) and 113 kindergartens (KGs) in all 18 geographical 5 
districts in Hong Kong.  6 
Results: The overall carriage rates of S. aureus and MRSA were 27.6% (95% confidence 7 
interval [CI], 24.8%-28.5%) and 1.3% (95% CI, 0.8%-1.8%), respectively. Molecular typing 8 
(staphylococcal cassette chromosome mec [SCCmec], sequence type [ST], clonal cluster 9 
[CC]) showed that all the 28 MRSA isolates had SCCmec IV (n=13) or V (n=15) including 10 
12 isolates with community-associated-MRSA genotypes (ST59-IV/V, ST30-IV, ST88-V), 11 
10 isolates with healthcare-associated-MRSA genotypes (ST45-IV/V, CC5-IV and ST630-V) 12 
and six isolates with novel genotypes (ST10-V, CC1-IV). Spa typing indicated that there was 13 
some within and between DCCs/KGs transmission of certain MRSA and Methicillin-14 
sensitive S. aureus strains but this was not extensive.  15 
Conclusion: Our findings indicate the potential for DCCs to be a reservoir for emerging 16 
MRSA genotypes and highlight the need to enhance education and infection control measures 17 
to reduce their cross-transmission in this population.  18 
 19 
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*Abstract
 2 
Introduction 
Nasal carriage of Staphylococcus aureus is an important risk factor for staphylococcal 
infections.
1,2
 Carriers of S. aureus have an increased risk of infection caused by the same 
strains they carry.
1
 When S. aureus colonization is eradicated, the risk of infection is 
reduced.
1,2
 Accordingly, nasal carriage of S. aureus has been widely used as an indicator to 
assess the antibiotic resistance of S. aureus and methicillin-resistant S. aureus (MRSA) in 
different populations.
3-5
 Young children and day care center (DCC) attendance are recognized 
to be important risk factors for community-associated (CA)-MRSA.
1,4
 DCCs due to their 
crowded environment, inadequate hygienic conditions, frequent close contacts, and heavy 
exposures to antimicrobials among the attendees are a favorable environment for 
transmission of S. aureus and MRSA.  
In Hong Kong, the 7-valent pneumococcal conjugate vaccine has been available in the 
market since October 2005.
6
 Since September 2009, PCV7 was incorporated into the 
childhood immunization program with a three plus one schedule. The 10-valent and 13-valent 
pneumococcal conjugate vaccines were marketed in August 2009 and May 2010, 
respectively.
6
 Previous studies suggested that use of the pneumococcal conjugate vaccines 
were associated with an increased risk for S. aureus otitis media
7
 and that nasopharyngeal 
colonization with S. pneumoniae, especially the PCV7 types was inversely related to 
nasopharyngeal
8
 and nasal
9,10
 carriage of S. aureus. This has raised concerns that 
implementation of pneumococcal vaccination in children may facilitate the spread of S. 
aureus and CA-MRSA.
7,9
 
In Hong Kong, about 30% of children aged 2 to 5 years attended DCC for more than 4 
hours a day on a regular basis.
11
 In this study, we investigate the prevalence of and risk 
factors associated with S. aureus and MRSA nasal carriage in a large sample of children 
 3 
attending DCCs and kindergartens (KGs). The relationship between Streptococcus 
pneumoniae and S. aureus colonization were also studied.  
 
Patients and methods 
Study design and participants 
Two specimens (one nasal and one nasopharyngeal swabs) were collected from children 
between 2 and 5 years of age who attended DCCs or KGs in Hong Kong during September 
2009 to April 2010.  In brief, Hong Kong is divided into 18 geographical districts, and the 
sample size of each district was calculated according to the number of DCC and KG places in 
each district.
11
 Ages of children who attend DCC and KG range from 2 to 6 years and 3 to 6 
years, respectively. Normally, all children attend 5 days per week for 7 to 9 hours a day in 
DCC and for 3 to 4 hours a day in a KG. Out of the total of 147,516 DCC and KG places in 
2007, DCC accounted for 30% while KG accounted for 70%. This ratio was used to calculate 
the number of children to be recruited from DCC and KG from each district to make the 
targeted study population of about 2000. Parental consent was obtained by the research staff. 
The protocol is approved by the Institutional Review Board at the Hong Kong West 
Cluster/University of Hong Kong. 
A standardized questionnaire was used to obtain the following information from 
parents of participating children: household size, overcrowding (≤5.5 m/person in accordance 
with the guideline of the Hong Kong Housing Authority), number and age of siblings, 
participant demographics, medical history, presence of symptoms of upper respiratory tract 
infection (URTI) symptoms at the time of sampling, recent use of antibiotics (past 3 months), 
vaccination history, physician visits (past 3 months) and prior hospitalization (past 1 year).  
 
Microbiological methods  
 4 
Nasopharyngeal cultures were obtained with a alginate-tipped swab on a flexible alumin wire 
(TRANSWAB per nasal, Medical Wire and Equipment Co. Ltd, Corsham, Wilts, England) 
and nasal cultures of both nares were obtained with sterile rayon swabs (TRANSWAB; 
Medical Wire and Equipment Co. Ltd). All specimens were obtained by three trained nurses. 
The swabs were transferred to the microbiology laboratory at the University of Hong Kong 
within 6 hours of collection in Amies transport media. Nasal swab from each subject was 
inoculated into a mannitol-salt broth medium (Oxoid) and incubated aerobically at 35 
o
C for 
24 hours. Turbid broths were subcultured onto two agar plates, ChromID MRSA (bioMerieux, 
France) and mannitol salt agar. For selective isolation of S. pneumoniae, nasopharyngeal 
swabs were inoculated onto 5% horse blood agar supplemented with gentamicin (2 g/ml) 
and incubated in 5% CO2 for 16 to 24 hours. Bacterial colony morphology, Gram stain, and 
the following tests were used to identify an organism as S. aureus: latex agglutination (Slidex 
Staph Plus, bioMerieux, France), tube coagulase, mannitol, ornithine and DNase. For S. 
pneumoniae, the isolates were identified by colony morphology, Gram stain, optochin 
susceptibility, and bile solubility. Isolates with atypical optocin/bile solubility test results 
were confirmed by a slide co-agglutination test (Phadebact Pneumococcus Test, Remel). 
Antimicrobial susceptibility testing was performed by the disc diffusion method in 
accordance with the Clinical and Laboratory Standard Institute (CLSI) recommendations. 
Cefoxitin discs were used for phenotypic detection of methicillin resistance. The D-test was 
used to detect inducible resistance to clindamycin. Quality control strains were included on 
each day of testing. The serotypes of the S. pneumoniae isolates were determined by 
multiplex PCR and the quellung reaction.
6
 Findings for the serotype distribution have been 
reported elsewhere.
12
    
 
Molecular studies 
 5 
The primers SpaF1 and SpaR1 were used to amplify the polymorphic X region of protein 
A.
13,14
 Repeat regions and spa types were analyzed according to RIDOM. MLST was 
performed as described elsewhere.
15
 The SCCmec types and presence of PVL genes were 
determined as previously described.
16-18
 SCCmec types were designated according to the ccr 
type and mec class combinations.
14,19
 MRSA clones were named according to their MLST 
and SCCmec types.
20
 The following MRSA strains were used as a positive control for 
SCCmec types (conventional/ alternative nomenclature): COL (type I/1A), PER34 (type 
IA/1A), BK2464 (type II/2A), ANS46 (type III/3A), HU25 (type IIIA/3A), HDE288 (type 
VI/4B) and HK1A2 (type V/5C).
14,16,17
 Multiplex PCR assays were used for detection of 
genes encoding resistance to macrolides-linocosamindes-streptogramin B antibiotics (ermA, 
ermB, ermC and mef) and aminoglycosides (aacA-aphD).
21,22
 
 
Statistic analysis 
The StatMate (GraphPad Software, CA, USA) was used to determine the power for the 
sample size in this study. We expected the S. aureus and S. pneumoniae carriage rates to be 
30% and 15%, respectively.
8,11
 To detect a difference of at least 6% in S. aureus carriage 
rates among S. pneumoniae carriers and noncarriers with alpha = 0.05 (two-tail significance) 
and 80% power, a sample size of 1000 children in each group was needed. The chi-square 
test or the Fisher exact test was used for categorical variable. Continuous variables were 
tested by the Student t test. The statistical package SPSS, version 14.0 (SPSS, Hong Kong), 
was used for all analyses. A P value of less than 0.05 was considered to be statistically 
significant.  
 
Results 
Characteristics of the study population 
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From September 2009 to April 2010, a total of 2211 children were enrolled from 79 DCCs 
and 113 KGs in the study. The mean age ( standard deviation [SD]) for the children was 3.9 
 0.9 years. About one-half of the children were male (52.0%). The mean  SD household 
size was 4.4  1.2. Twenty-eight percent (614/2211) of surveyed children had siblings five 
years old or below. One hundred and five (4.7%) of the 2211 children lived in an overcrowed 
environment. In this cohort of children, 9.7% (214/2211) reported acute upper respiratory 
symptoms at the time of sampling, 62.7% (1386/2211) reported prior physician visit(s), 
30.6% (677/2211) reported prior antibiotic use, and 28.1% (622/2211) had received at least 
one dose of the 7-valent pneumococcal conjugate vaccine (PCV7). Among children with 
pneumococcal vaccination, 80.7% (502/622) were considered age appropriately vaccinated 
for PCV7.  
 
S. aureus carriage and association with S. pneumoniae carriage 
Overall, 610 (27.6%) children were found to carry S. aureus, including 582 children with 
MSSA alone and 21 children with MRSA alone and 7 children with both MSSA and MRSA. 
The nasal carriage rates of MRSA and MSSA were 1.3% (28/2211, 95% confidence interval 
[CI] 0.8%-1.8%), and 26.6% (589/2211, 95% CI, 24.8%-28.5%), respectively. The age-
stratified S. aureus carriage rate was 19.8% (34/172) for children aged 2 years, 24.2% 
(133/549) for children aged 3 years, 30.3% (230/759) for children aged 4 years and 29.1% 
(213/731) for children aged 5 years (P = 0.007). Those for MRSA carriage were 2.3% (4/172) 
for those aged 2 years, 1.5% (8/549) for those aged 3 years, 0.9% (7/759) for those aged 4 
years and 1.2% (9/731) for those aged 5 years. The 28 MRSA isolates were recovered from 
children attending 10 DCCs and 15 KGs. Two isolates each was found in three DCCs/KGs. 
The remaining 22 DCCs/KGs had one isolate each. The 25 DCCs/KGs with MRSA carriers 
had distribution in 14 of the 18 geographical districts in Hong Kong. The four geographical 
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districts without MRSA carriers were K4, NT2, NT4 and NT7. The MRSA carriage rate in 
the other 14 districts ranged from 0.7% (NT8) to 3.4% (K5). 
Overall, the S. pneumoniae carriage rate was 15.7% (347/2211). S. aureus carriage 
among S. pneumoniae carriers was 29.1% (101/347) vs. 27.3% (509/1864) in S. pneumoniae 
noncarriers (P = 0.1) (Table 1). S. pneumoniae carriage among S. aureus carriers was 16.6% 
(101/610) vs. 15.4% (246/1601) in S. aureus noncarriers. If carriage of the two organisms 
were independent, the expected dual carriage would be 4.3% (i.e. S. aureus 27.6%  S. 
pneumoniae 15.7%). Dual colonization with S. aureus and S. pneumoniae was found in 101 
(4.6%, 95% confidence interval 3.7%-5.5%) children. There was no association between S. 
aureus carriage and PCV7-type or non-PCV7 type S. pneumoniae carriage (P = 0.3). Similar 
lack of association with S. pneumoniae carriage was found following further stratification by 
MRSA and MSSA. The findings indicated that S. aureus colonization was not affected by S. 
pneumoniae or vaccine-type S. pneumoniae co-colonization. 
 
Potential risk factors for S. aureus carriage 
 Table 2 summarized findings from the univariate analyses. S. aureus carriage was 
significantly and negatively associated with younger age but not the other variables. Due to 
the small number of MRSA carriers, none of the variables were found to have statistically 
significant association with MRSA carriage.  
A history of PCV7 vaccination did not interfere with S. aureus carriage. S. aureus and 
MRSA carriage was 29.7% (95% CI, 25.9%-33.8%) and 1.6% (0.8%-3.1%) among fully 
vaccinated children, 25.0% (18.1%-33.4%) and 1.7% (0.5%-5.9%) among partially 
vaccinated children and 27.1% (95% CI, 24.9%-29.4%) and 1.1% (95% CI, 0.7%-1.8%) 
among non-vaccinated children, respectively. To further evaluate whether PCV7 vaccination 
and S. pneumoniae carriage modified the risk of S. aureus colonization, a multivariate 
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analysis was conducted to adjust for confounding from the other child and household factors. 
The finding showed that only young age (OR 0.6, 95% CI 0.4-0.9, P = 0.02) was a negative 
predictor for S. aureus carriage. No significant association was found for at least one dose of 
PCV7 vaccination (P=0.3), fully vaccinated for PCV7 (P=0.2), colonization with S. 
pneumoniae (P=0.5) and colonization with PCV7-type S. pneumoniae (P=0.4).  
 
Antimicrobial susceptibility 
Drugs active against >90% of both MSSA and MRSA isolates include cotrimoxazole, 
minocycline, fusidic acid and rifampicin. Overall, the erythromycin resistance rate was 
41.8% (258/617) including 40.3% (241/598) for MSSA and 60.7% (17/28) for MRSA. 
Among erythromycin-resistant isolates, 17.4% (45/258) and 75.6% (195/258) had 
constitutive (cMLS phenotype) and inducible (iMLS phenotype) resistance to clindamycin, 
respectively. The remaining 18 erythromycin-resistant isolates (all MSSA) had the M 
phenotype (i.e. resistant to erythromycin only). Another six isolates (all MSSA) were 
resistant to clindamycin alone (L phenotype). The iMLS phenotype predominated among 
MSSA (78.4%, 189/241), while the cMLS phenotype was prevalent among MRSA (64.7%, 
11/17). MRSA isolates were significantly more likely than MSSA to have multidrug 
resistance (i.e. co-resistance to three or more non-β-lactam drugs). The antimicrobial agents 
that were less likely to be susceptible among MRSA isolates than MSSA isolates included 
erythromycin (MRSA, 39.3% sensitive vs. MSSA, 59.1% sensitive, P = 0.04), clindamycin 
(39.3% vs. 61.1%, P = 0.02), gentamicin (82.1% vs. 97.6%, P < 0.001), tetracycline (67.9% 
vs. 86.4%, P = 0.006), chloramphenicol (85.7% vs. 97.5%, P < 0.001) and ciprofloxacin 
(75.0% vs. 96.1%, P < 0.001). 
 
Genotypic characteristics 
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Table 3 summarized the genotypic and epidemiologic features for the 28 MRSA isolates. 
Molecular typing showed that the isolates had either SCCmec type IV (n=13) or type V 
(n=15). Most (26/28) the isolates were found to belong to six lineages (clonal complex [CC]-
SCCmec type): CC1-IV, CC5-IV, CC10-V, CC30-IV, CC45-IV/V and CC59-IV/V. The 
remaining two sporadic isolates belonged to ST630-V and ST88-V. The PVL gene was 
detected in seven isolates of the ST30 (n=2), ST59 (n=4) and ST88 (n=1) lineages. A total of 
15 different spa types were found. The spa types with >1 isolate included t437 (n=6), t1081 
(n=6), t1244 (n=3) and t019 (n=2). The remaining spa types were detected one isolate each: 
t002, t062, t114, t1861, t3485, t3590, t441, t5554, t6294, t6383 and t7316.  
Analysis of spa type distribution in the DCCs and KGs showed that there was 
evidence of intra- and inter-DCCs/KGs transmission. The genotypic features for the three 
MRSA clusters in the three DCCs/KGs were:  HKS02 (two isolates, both t1081, ST45-V and 
PVL negative), ST02 (two isolates, both t437, ST59-V and PVL positive) and YTM02 (two 
isolates, both PVL negative, one had t6383, ST1774-V and one had t1244, ST10-IV). Of the 
spa types with >1 isolates, t437 was found in five DCCs/KGs, t1081 in five DCCs/KGs, 
t1244 in three DCCs/KGs and t019 in two DCCs/KGs.   
Three MRSA clones, including CC5, CC45 and CC59 were found to exhibit 
multidrug resistance phenotypes involving chloramphenicol, ciprofloxacin, clindamycin, 
erythromycin, gentamicin and/or tetracycline. In contrast, CC1, CC10 and ST88 had 
resistance limited to erythromycin and/or clindamycin. CC30 and ST630 isolates were 
sensitive to all the non-β-lactam antibiotics. The 17 erythromycin-resistant isolates were 
found to possess the ermB (n=8, all had cMLS phenotype) or ermC gene (n=9, three had 
cMLS and six had iMLS phenotype).  
A subset of randomly chosen 101 MSSA isolates was further analyzed by spa typing. 
This subset of isolates had the following MLS phenotype: cMLS (n=7), iMLS (n=29), M 
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(n=2), L (n=1) and none (n=62). The isolates belonged to 51 spa types. Of these, 61 isolates 
had 11 spa types with two or more isolates each: t338 (n=13), t189 (n=12), t091 (n=11), t084 
(n=5), t701 (n=4), t012 (n=3), t164 (n=3), t363 (n=3), t5864 (n=3), t5864 (n=3), t002 (n=2) 
and t122 (n=2). The remaining 40 spa types had one isolate each: t008, t019, t021, t034, t091, 
t094, t1081, t114, t1156, t118, t127, t148, t1950, t2019, t2091, t2883, t304, t3272, t3697, 
t4445, t458, t4615, t5078, t5622, t571, t584, t7254, t7315, t7316, t7318, t7319, t7320, t7321, 
t7322, t7325, t7397, t7402, t7407, t935 and t937. These results indicated that there were only 
limited MSSA transmissions among the children. Six (6.0%) of the 101 MSSA isolates 
shared spa types found in the MRSA isolates. These include two isolates with t002 and one 
isolates each with t019, t114, t1081, and t7316. The 36 MSSA isolates with iMLS and cMLS 
phenotypes were found to belong to 18 different spa types. Twelve (92.3%) of the 13 spa 
t338 strains had the iMLS phenotype. The 12 strains were obtained from 12 different 
DCCs/KGs. All the remaining 17 spa types associated with MLS resistance had one to three 
isolates each.  
 
Discussion 
The prevalence of S. aureus carriage among children who attended DCCs (28.1%) 
was similar to those who attend KGs (27.4%). In comparison, the S. aureus carriage rate 
among DCC attendees was 18.1% for 1163 children in the United States in 2007-2009 
5
 and 
31.1% for 1192 children in Brazil in 2005.
4
 According to Census data, there were 181,000 
children aged 2-5 years in Hong Kong in 2009. The 1.3% MRSA prevalence translates into 
2292 (95% CI, 1593-3312) children colonized with MRSA in the community. The MRSA 
burden is six times the number of CA-MRSA notified to the Department of Health in 2009.
14
 
The results are similar to the 1.3% and 1.2% MRSA carriage rates found among DCC 
attendees in the two studies conducted in the United States and Brazil, respectively.
4,5
 but was 
 11 
lower than the MRSA colonization rates among Taiwanese (6.2% to 9.2% in 2005-2008)
9
 
and Korean (9.3% in 2008) children.
23
 In Hong Kong, large scale public health campaigns on 
hand hygiene have been implemented in DCCs and KGs during 2003-2009.
24
 Such 
interventions could have reduced within centers transmission of MRSA and explained why 
our MRSA prevalence was substantially lower than those reported for other Asian 
countries.
9,23,25
  
Molecular analysis of the colonizing MRSA strains revealed that they were 
genetically diverse and no single clone predominated. These include CA-MRSA clones that 
are associated with infections in the community (ST30-IV and ST59-V)
18
 as well as a major 
MRSA clone that is endemic in our hospitals (ST45-IV/V).
14,19
 Although the ST239-III and 
ST5-II clones are also endemic in our hospitals and had been reported among patients without 
risk factors for healthcare-associated (HA)-MRSA infections in other Asian countries,
14,26
 
these HA-MRSA clones were not found in the present study. The relatively smaller sizes of 
the SCCmec types in ST45-IV/V might give this clone an advantage for its spread from 
hospitals to the community. Since the children with ST45-IV/V colonization had no history 
of prior hospitalization, they might have acquired the strains from other people with 
healthcare risk factors. Two MRSA genotypes including ST10-V and ST1-IV were detected 
for the first time in Hong Kong. ST1-IV is one of the indigenous CA-MRSA clone in West 
Australia and have been found in United States (known as USA400), Europe and Asia.
27
 
Unlike USA400, ST1-IV in Western Australia is usually PVL-negative. Similar PVL-
negative ST1-IV variants have also been found to colonized DCC attendee in South Korea.
23
 
ST10-V is a novel MRSA genotype and has not been reported previously. In the MLST 
database, there were only three ST10 S. aureus isolates and all three were MSSA. These new 
MRSA strains could have arisen de novo within Hong Kong or be imported from elsewhere.  
 12 
Spa typing analysis showed that the colonizing MSSA isolates were genetically more 
diverse than the colonizing MRSA isolates. Although a few of the MSSA isolates shared 
common spa types with the MRSA isolates, the leading spa types among MSSA isolates were 
different from those of the MRSA isolates suggesting that the MRSA isolates evolved 
independently.  
Previous studies indicated that the difference in S. aureus rates among S. pneumoniae 
carriers and noncarriers ranged 6% to 22.7%.
8-10,28,29
 The completed results indicated that the 
present study was powered to detect a difference of at least 7.4% which is within the 
expected range. However, our investigations did not find an association between nasal 
carriage of S. aureus, MRSA and nasopharyngeal carriage of S. pneumoniae. It is important 
to point out that the inverse relationship between S. aureus colonization and S. pneumoniae 
carriage was not observed in all the studies. One study involving 1968 healthy children aged 
3 month to 7 years (80% power to detect 5% difference) and one study involving 1783 young 
children aged 6-24 months with acute otitis media (80% power to detect 4% difference) did 
not find any difference in colonization with S. aureus among children who were and were not 
colonized with S. pneumoniae.
30,31
 The carriage of S. aureus is also influenced by interactions 
from other co-colonizing organisms such as Haemophilus influenzae.
28
 In addition, we found 
no association between PCV7 use and S. aureus carriage. As reported recently, PCV7 
vaccination may only temporary induce an increase in S. aureus carriage in children around 
12 months of age.
32
 Our study was cross-sectional in nature and the vaccinated children 
received PCV7 over a wide range of different times. This may explain the discordant 
observations. Finally, comparison of findings from the published studies are cofounded by 
variations in specimen collection techniques (one nasopharyngeal swab for both organisms
8,31
 
versus two separate nasal and nasopharyngeal swabs
9,30
 for S. aureus and S. pneumoniae) and 
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laboratory methodologies (culture of S. aureus by direct plating
30,31
 versus a broth 
enrichment
8
 before plating).  
 The main strength of this study is that it is a comprehensive study involving children 
who were enrolled according to the distribution of DCCs and KGs places in the whole 
territory. Nonetheless, it has several limitations. Firstly, it is a cross-sectional study. It would 
not be possible to assess the dynamic changes in S. aureus carriage. Secondly, the small 
number of MRSA-colonized children limited our ability to statistically demonstrate risk 
factors associated with MRSA colonization. The variables that was more common among the 
MRSA colonized children in the present study, including young age, DCC attendance, and 
overcrowding have previously been shown to be associated with MRSA colonization.
4,9
  
 In summary, this study showed that 1.3% of children aged 2-5 years attending DCCs 
and KGs were colonized with MRSA of diverse genotypes. In addition, erythromycin-
resistant MSSA was highly prevalent in this population. The results indicate the potential for 
DCCs and KGs to act as reservoirs for different types of antimicrobial-resistant S. aureus. 
Thus, continued efforts to enhance hygiene in the DCCs and KGs are necessary to slow down 
the transmission of these pathogens in the community.
24,33
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Table 1. Tabulation of S. aureus, MRSA, MSSA and S. pneumoniae carriage among children 
aged 2-5years in Hong Kong, 2009-2010 
Category S. aureus carriage
a 
 All  
serotypes (A) 
Non-PCV7  
serotypes (A1) 
PCV7  
serotypes (A2) 
S. pneumonie 
noncarrier (B) 
 
Any S. aureus 29.1 (101/347) 27.4 (43/157) 30.5 (58/190) 27.3 (509/1864) 
MRSA 1.7 (6/347) 1.9 (3/157) 1.6 (3/190) 1.2 (22/1864) 
MSSA 27.4 (95/347) 25.5 (40/157) 28.9 (55/190) 26.5 (494/1864) 
a 
Percentage (Number/subtotal) of children with S. aureus, MRSA or MSSA carriage among 
those children who were or were not colonized with S. pneumoniae. The S, aureus, MRSA 
and MSSA carriage rates in the groups with different S. pneumoniae colonization status were 
compared (A vs. B, A1 vs. B and A2 vs. B). No significant difference was found for all 
pairwise comparisons (Chi square or Fisher exact test, >0.05). 
Table
 2 
Table 2. Demographic and clinical characteristics of S. aureus and MRSA carriage among 
children, Hong Kong 
 S. aureus carriage (%) P 
 No  
(n=1601) 
Yes  
(n=610) 
 
Child factors    
Male sex 51.8 51.3 0.8 
Young age 8.6 5.6 0.02 
DCC attendance 32.4 33.1 0.7 
PCV7 vaccination     
    At least one dose 27.7 29.3 0.4 
     Completely vaccinated 22.0 24.4 0.2 
Current URTI 9.9 9.2 0.6 
Prior antibiotic use 29.9 32.5 0.2 
Prior hospitalization 7.9 6.2 0.1 
Recent physician visit 62.5 63.3 0.9 
Household factors    
No. of household members 4.4  1.2 4.4  1.2 0.8 
Overcrowding 4.4 6.0 0.1 
PCV7 vaccination in siblings 11.1 10.8 0.8 
Having young siblings 27.4 28.9 0.5 
DCC, day care center; PCV7, 7-valent pneumococcal vaccine 
 
 
 3 
Table 3. Genotypic and phenotypic characteristics of 28 MRSA isolates carried by children in Hong Kong, 2009-2010 
MRSA clones n MLST
a 
spa type Resistance pattern
b 
Resistance determinants
c 
ST59-IV/V 9 ST59 (9) t437 (6), t441 (1), t3485 (1), 
t3590 (1) 
CHL (4), ERY (8), TET (6) ermB (8) 
ST45-IV/V 7 ST45 (7) t1081 (6), t1861 (1) CIP (6), ERY (2), GEN (4), TET (3) ermC (2), aacA-aphD (4) 
ST10-V 4 ST10 (4) t7316 (1), t1244 (3) ERY (4) ermC (10) 
CC1-IV 2 ST1 (1), 
ST1774 (1) 
t114 (1), t6383 (1) ERY (1) ermC (1) 
ST30-IV 2 ST30 (2) t019 (2) None  
CC5-IV 2 ST5 (1), 
ST1773(1) 
t002 (1), t062 (1) CIP (1), ERY (1), GEN (1) ermC (1), aacA-aphD (1) 
ST630-V 1 ST630 (1) t5554 (1) None  
ST88-V 1 ST88 (1) t6292 (1) ERY ermC (1) 
a
Parentheses indicate the number of isolates. CC, clonal cluster; ST, sequence type. ST630 (12-3-1-1-4-4-3) is single locus variant (SLV) of ST8 
(3-3-1-1-4-4-3). ST1774 (10-1-1-8-1-1-2) differ from ST1 (1-1-1-1-1-1-1) in three loci. ST1773 (1-255-1-4-119-1-10) is a double loci variant of 
ST5 (1-4-1-4-12-1-10). 
b
For the following eight drugs:  chloramphenicol (CHL), ciprofloxacin (CIP), cotrimoxazole), erythromycin (ERY), fusidic acid, gentamicin 
(GEN), rifampicin and tetracycline (TET). 
c 
aacA-aphD, aminoglycoside resistance gene encoding the bifunctional enzyme, 6'-aminoglycoside N-acetyltransferase/2''-aminoglycoside 
phosphotransferase; ermB and ermC, genes encoding macrolide-lincosamide-streptogramin B resistance.     
